Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-05-04 to 2023-05-05
Current total value of award: $6.08
Description: 4560982425!TEMAZEPAM 30 MG CAPSULE 100S